Target General Information
Target ID T01575
Target Name Sphingosine 1 phosphate lyase 1
Synonyms S1PL; SP-lyase 1; SPL 1; Sphingosine-1-phosphate aldolase; hSPL; SGPL1
Target Type Clinical Trial
Gene Name SGPL1 {ECO:0000312|HGNC:HGNC:10817}||Synonyms=KIAA1252 {ECO:0000303|PubMed:10574462}
Biochemical Class Carbon-carbon lyase
UniProt ID SGPL1_HUMAN
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals
Disease Rheumatoid arthritis
Example drug LX2931 Phase 2 [522666], [1572592]
Tissue Synovial tissue
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: 0.38
Z-score: 0.90
P-value: 1.63E-02
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
Target Gene Expression Profiles in Other Tissues of Healthy Individuals
Reference
Ref 522666ClinicalTrials.gov (NCT00903383) Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate. U.S. National Institutes of Health.
Ref 1572592NCBI GEO: archive for functional genomics data sets--update.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.